[NP_O1] Oral Session 1

Sat. Oct 12, 2019 8:40 AM - 10:20 AM Room 8 (404)

座長：糸川　昌成（公益財団法人東京都医学総合研究所）、猿渡　淳二（熊本大学大学院生命科学研究部薬物治療学分野）

+Add all to schedule

8:40 AM - 8:53 AM

[NP-O1-1] Brain histamine improves memory retrieval impairment

^○Hiroshi NOMURA, Ayame KUBO, Kyoka NISHIMURA, Masabumi MINAMI (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University)

8:53 AM - 9:06 AM

[NP-O1-2] APC-100, a small molecular compound based neuroregeneration therapy for Alzheimer’s disease

^○Kiminobu SUGAYA (College of Medicine, University of Central Florida)

9:06 AM - 9:19 AM

[NP-O1-3] Pathological analysis of Parkinson's disease using Parkinson's disease patient-specific iPS cell-derived GABAergic neurons

^○Reiko KAGAWA¹, Naoko KUZUMAKI^{1, 2}, Chizuru IWASAWA¹, Yukari SUDA², Nobutaka HATTORI³, Hideyuki OKANO⁴, Minoru NARITA^{1, 2} (1. Dept. Pharmacol., Hoshi Univ., Tokyo, Japan, 2. L-StaR, Hoshi Univ., Tokyo, Japan, 3. Dept. Neurol,, Juntendo Univ. Sch. Med., Tokyo, Japan, 4. Dept. Physiol., Keio Univ. Sch. Med., Tokyo, Japan)

9:19 AM - 9:32 AM

[NP-O1-4] Re-establishment of [³⁵S]GTPγS binding/immunoprecipitation assay in rat brain membranes

^○Yuji ODAGAKI, Masakazu KINOSHITA (神経精神科・心療内科)

9:32 AM - 9:45 AM

[NP-O1-5] Autistic Behavioral Phenotypes in FMR1 Knockout Mice Under Group-Housed Homecage Environment

^○Seico BENNER, Yosuke KAMENO, Hidenori YAMASUE (Department of Psychiatry, Hamamatsu University School of Medicine, Shizuoka, Japan)

9:45 AM - 9:58 AM

[NP-O1-6] Molecular basis underlying the comorbidity between autism spectrum　disorder and epilepsy

^○Tsuboi DAISUKE¹, IMRUL HASSAN MD CHOWDHURY ¹, Yamada REI², Ohtsuka TOSHIHISA³, Kaibuchi KOZO¹ (1. Department of Cell Pharmacology, Nagoya University, 2. Department of Cell Physiology, Nagoya University, 3. Department of Biochemistry, Yamanashi University)

9:58 AM - 10:20 AM

[NP-O1-7] Dopamine synthesis capacity is differently associated with pre- and postsynaptic dopamine function: A PET study with L-[β-¹¹C]DOPA, [¹⁸F]FE-PE2I and [¹¹C]raclopride

Yasuharu YAMAMOTO^{1, 2},^○ Keisuke TAKAHATA¹, Manabu KUBOTA¹, Yasunori SANO^{1, 2}, Hitoshi SHIMADA¹, Yuhei TAKADO¹, Chie SEKI¹, Yasuyuki KIMURA³, Harumasa TAKANO⁴, Kenji TAGAI¹, Shin KUROSE², Hiroyoshi TAKEUCHI², Kazuki KAWAMURA⁵, Ming-Rong ZHANG⁵, Masaru MIMURA⁵, Makoto HIGUCHI¹ (1. National Institutes for Quantum and Radiological Science and Technology, 2. Department of Neuropsychiatry, Keio University School of Medicine, 3. Centor for Development of Advanced Medicine for Dementia, 4. Integrative Brain Imaging Center, 5. National Institutes for Quantum and Radiological Science and Technology)